日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T

血清学和PET/CT反应动力学在接受BCMA CAR-T治疗的多发性骨髓瘤患者中的预后价值

Gustine, Joshua N; Scaringi, John A; Bauer, Fabian; Cirstea, Diana D; Branagan, Andrew R; Puliafito, Benjamin R; Maus, Marcela V; Frigault, Matthew J; Yee, Andrew J; Mahmood, Umar; Raje, Noopur S

Vaccination during bispecific antibody treatment for myeloma

在接受双特异性抗体治疗多发性骨髓瘤期间进行疫苗接种

Banerjee, Rahul; Raje, Noopur S

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

在 CARTITUDE-1 研究中,接受 Ciltacabtagene Autoleucel 治疗的复发/难治性多发性骨髓瘤患者获得长期(≥5 年)缓解和生存。

Jagannath, Sundar; Martin, Thomas G; Lin, Yi; Cohen, Adam D; Raje, Noopur; Htut, Myo; Deol, Abhinav; Agha, Mounzer; Berdeja, Jesus G; Lesokhin, Alexander M; Liegel, Jessica J; Rossi, Adriana; Lieberman-Cribbin, Alex; Usmani, Saad Z; Dhakal, Binod; Parekh, Samir; Li, Hui; Wang, Feng; Montes de Oca, Rocio; Plaks, Vicki; Sun, Huabin; Banerjee, Arnob; Schecter, Jordan M; Lendvai, Nikoletta; Madduri, Deepu; Lengil, Tamar; Zhu, Jieqing; Koneru, Mythili; Akram, Muhammad; Patel, Nitin; Costa Filho, Octavio; Jakubowiak, Andrzej J; Voorhees, Peter M

Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment

环磷酰胺可减轻ciltacabtagene autoleucel治疗后出现的非ICANS神经毒性

Blumenberg, Viktoria; Puliafito, Benjamin R; Graham, Charlotte E; Leick, Mark B; Chowdhury, Md Raihan; King, Maxx; Harris, Deshea L; Raje, Noopur S; Branagan, Andrew R; Yee, Andrew J; Cirstea, Diana; Gallagher, Kathleen M E; Dietrich, Jörg; Maus, Marcela V; Frigault, Matthew J

Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes

达雷妥尤单抗/来那度胺/地塞米松治疗不适合移植的新诊断多发性骨髓瘤:MAIA长期疗效

Facon, Thierry; Moreau, Philippe; Weisel, Katja; Goldschmidt, Hartmut; Usmani, Saad Z; Chari, Ajai; Plesner, Torben; Orlowski, Robert Z; Bahlis, Nizar; Basu, Supratik; Hulin, Cyrille; Quach, Hang; O'Dwyer, Michael; Perrot, Aurore; Jacquet, Caroline; Venner, Christopher P; Raje, Noopur; Tiab, Mourad; Macro, Margaret; Frenzel, Laurent; Leleu, Xavier; Cook, Gordon; Wang, George; Pei, Huiling; Krevvata, Maria; Carson, Robin; Borgsten, Fredrik; Kumar, Shaji K

The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma

CAR-T细胞疗法可重塑内源性T细胞图谱,并预测多发性骨髓瘤的治疗反应。

Frede, Julia; Poller, Julia C; Shi, Kayleen; Stuart, Hannah; Sotudeh, Noori; Havig, Claire; Lim, Klothilda; Wiggers, Caroline R M; Cho, Eugene Y; Vijaykumar, Tushara; Liu, Jianlin; Waldschmidt, Johannes M; Nair, Monica S; Anand, Praveen; Dimitrova, Valeriya; Montanaro, Anna; Yee, Andrew J; Munshi, Nikhil C; Anderson, Kenneth C; Martin, Nathan; Kaiser, Shari M; Raab, Marc-Steffen; Raje, Noopur S; Knoechel, Birgit; Lohr, Jens G

Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide

本研究对接受PVX-410疫苗(靶向XBP1/CD138/CS1抗原)和西他诺司他(一种组蛋白去乙酰化酶抑制剂,HDACi)联合或不联合来那度胺治疗的冒烟型多发性骨髓瘤患者进行了Ib期临床试验,并分析了接受西他诺司他治疗的冒烟型多发性骨髓瘤患者的免疫特征。

Cirstea, Diana; Shome, Rajib; Samur, Mehmet; Talluri, Srikanth; Connolly, Joseph J; Wright, Alexandra Jean; Duvallet, Emilie; Joyce, Amanda N R; Lively, Kathleen; Basinsky, Gina; Yee, Andrew J; Chase, Cristiana Costa; Malek, Ehsan; Niesvizky, Ruben; Richardson, Paul G; Raje, Noopur S

Radiation therapy to manage isolated relapse after chimeric antigen receptor T-cell therapy in multiple myeloma

放射疗法用于治疗多发性骨髓瘤嵌合抗原受体T细胞疗法后的孤立性复发

Srinivas, Surbhi; Zhu, Lin L; Raje, Noopur; Patel, Chirayu G

Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma

纳武利尤单抗用于恢复CAR-T疗法难治性多发性骨髓瘤患者的T细胞功能

Waldschmidt, Johannes M; Sotudeh, Noori; Arora, Sankalp; Vijaykumar, Tushara; Anand, Praveen; Stuart, Hannah; Frede, Julia; Campbell, Tim; Kaiser, Shari M; Zheng, Xirong; Munshi, Nikhil C; Anderson, Kenneth C; Einsele, Hermann; Yee, Andrew J; Knoechel, Birgit; Lohr, Jens G; Raje, Noopur S

Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury

早期达雷妥尤单抗治疗可改善新诊断的多发性骨髓瘤合并肾损伤患者的肾脏预后。

Kim, E Bridget; Malespini, Jack E; Lei, Matthew; Han, Samuel S; Minsky, Cole W; Branagan, Andrew R; O'Donnell, Elizabeth K; Cirstea, Diana; Raje, Noopur S; Yee, Andrew J